Monitor for the actual sale on Form 4 to confirm execution. The $2.7M sale is modest relative to the $2.2B market cap and follows recent insider selling patterns. No immediate price catalyst — treat as routine portfolio diversification by an officer.
Price Chart
Executive Summary
Eric Warren, an officer of Mineralys Therapeutics, filed a Form 144 notice of intent to sell 104,124 shares of common stock, with an approximate market value of $2.7 million based on the filing date. The shares were acquired via a cashless exercise of employee stock options on June 26, 2026. This is a routine insider sale by an officer, not a transformative event, and the filing signals intent to sell, not a completed transaction.
Key Facts
- Filer: Eric Warren, an officer of Mineralys Therapeutics
- Shares to be sold: 104,124 shares of common stock
- Approximate market value: $2,696,321.98 (based on filing date price of ~$25.90/share)
- Acquisition: Shares acquired via cashless exercise of employee stock options on June 26, 2026
- Broker: Merrill Lynch, 225 Liberty Street, New York, NY
- Filing date: June 29, 2026; proposed sale date: June 26, 2026
- Exchange: NASDAQ
- Recent insider activity (30d): 3 sells totaling $425K prior to this filing
Financial Impact
Proposed sale of 104,124 shares valued at approximately $2.7 million, representing about 0.12% of the company's $2.2B market cap
Risk Factors
- Insider selling ahead of potential negative catalysts (e.g., clinical trial readouts, regulatory decisions) could signal lack of confidence
- Accumulation of insider sales over time may weigh on sentiment if not offset by insider buying
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001964306-26-000299 |
| Document: 0001964306-26-000299-index.html | 0001964306-26-000299 |
| Document: 0001964306-26-000299.txt | 0001964306-26-000299 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 12, 2026 7w ago | 3 | $26.09 $28.20 | ▲ +8.09% | ▲ +9.83% | $23.56 (−9.70%) |
Jul 23, 2026 10w ago | Insider Cluster | $26.71 $25.65 | ▼ −3.97% | ▼ −7.59% | $23.56 (−11.79%) |
Jul 21, 2026 10w ago | Insider Cluster | $27.52 $26.61 | ▼ −3.31% | ▼ −5.87% | $23.56 (−14.39%) |
Jul 16, 2026 11w ago | Insider Cluster | $27.08 $26.09 | ▼ −3.66% | ▼ −7.27% | $23.56 (−13.00%) |
Jun 30, 2026 13w ago | 144 | $26.89 $26.35 | ▼ −2.01% | ▲ +0.18% | $23.56 (−12.38%) |
Jun 29, 2026 13w ago | 144 | $26.88 $26.71 | ▼ −0.63% | ▼ −0.35% | $23.56 (−12.35%) |
Jun 18, 2026 15w ago | Insider Cluster | $24.63 $27.08 | ▲ +9.95% | ▲ +9.41% | $23.56 (−4.34%) |
Jun 17, 2026 15w ago | 144 | $24.63 $27.08 | ▲ +9.95% | ▲ +9.41% | $23.56 (−4.34%) |
Jun 11, 2026 16w ago | Institutional Cluster | $23.94 $28.96 | ▲ +20.97% | ▲ +19.08% | $23.56 (−1.59%) |
Jun 3, 2026 17w ago | 8-K | $25.06 $27.69 | ▲ +10.49% | ▲ +11.49% | $23.56 (−5.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access